Author:
Fu Shun-Jun,Shen Shun-Li,Li Shao-Qiang,Hua Yun-Peng,Hu Wen-Jie,Liang Li-Jian,Peng Bao-Gang
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference40 articles.
1. EI-serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.
2. Tang ZY. Hepatocellular carcinoma-cause, treatment, and metastasis. World J Gastroenterol. 2001;7:445–54.
3. Ng KK, Lo CM, Liu CL, Poon RT, Chan SC, Fan ST. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant. Arch Surg. 2008;143:68–74.
4. Kim do Y, Paik YH, Ahn SH, Youn YJ, Choi JW, Kim JK. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology. 2007;72:52–7.
5. Furihata T, Sawada T, Kita J, Iso Y, Kato M, Rokkaku K, et al. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy. Hepatogastroenterology. 2008;55:1705–9.